These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Reactivation of herpes virus infections by vaccination: evidence or coincidence?]. Walter R; Hartmann K; Pool V; Gargiullo P; Kuhn M Schweiz Med Wochenschr; 2000 Nov; 130(44):1685-8. PubMed ID: 11103441 [TBL] [Abstract][Full Text] [Related]
23. Editorial: vaccination against an oncogenic herpesvirus. Lancet; 1975 Mar; 1(7905):504-5. PubMed ID: 46967 [No Abstract] [Full Text] [Related]
24. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus. Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649 [TBL] [Abstract][Full Text] [Related]
25. Studies on the live-virus vaccine against infectious laryngotracheitis of chickens. II. Evaluation of the tissue-culture-modified strain C7 in laboratory and field trials. Izuchi T; Hasegawa A; Miyamoto T Avian Dis; 1984; 28(2):323-30. PubMed ID: 6331361 [TBL] [Abstract][Full Text] [Related]
26. Long-term field trials with the herpesvirus of turkeys vaccine against Marek's disease. Purchase HG; Okazaki W; Burmester BR Avian Dis; 1972 Apr; 16(1):57-71. PubMed ID: 4337318 [No Abstract] [Full Text] [Related]
27. [Virologico-serologic studies in patients with brain tumors]. Wohlrabe P; Sprössig M; Färber I; Wutzler P; Steube D; Schreiber D Zentralbl Neurochir; 1984; 45(2):152-8. PubMed ID: 6091370 [TBL] [Abstract][Full Text] [Related]
28. [Current problems posed by viruses of the herpes group]. Bricout F Pathol Biol (Paris); 1977 Mar; 25(3):143-5. PubMed ID: 193083 [No Abstract] [Full Text] [Related]
29. Prospects for herpesvirus vaccination--safety and efficacy considerations. Parks WP; Rapp F Prog Med Virol; 1975; 21():188-206. PubMed ID: 174154 [No Abstract] [Full Text] [Related]
30. The five human herpesviruses: infection, prevention, and treatment. Galasso GJ; Myers MW Adv Intern Med; 1984; 29():25-58. PubMed ID: 6324554 [No Abstract] [Full Text] [Related]
32. Studies on vaccination against infectious laryngotracheitis by the drinking water. Seimenis A; Menassé I Dev Biol Stand; 1976; 33():328-31. PubMed ID: 182588 [TBL] [Abstract][Full Text] [Related]
33. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection. Schleiss MR; Lacayo JC; Belkaid Y; McGregor A; Stroup G; Rayner J; Alterson K; Chulay JD; Smith JF J Infect Dis; 2007 Mar; 195(6):789-98. PubMed ID: 17299708 [TBL] [Abstract][Full Text] [Related]
34. Clinical trial of live attenuated Varicella vaccine in high risk susceptibles--a preliminary report. Gershon AA; Steinberg S; Borkowsky W Dev Biol Stand; 1982; 52():391-7. PubMed ID: 6299849 [No Abstract] [Full Text] [Related]
35. Effect of route of vaccination on the prevention of infectious laryngotracheitis in commercial egg-laying chickens. Fulton RM; Schrader DL; Will M Avian Dis; 2000; 44(1):8-16. PubMed ID: 10737639 [TBL] [Abstract][Full Text] [Related]
36. The guinea pig cytomegalovirus model of congenital human cytomegalovirus infection. Bia FJ; Miller SA; Davidson KH Birth Defects Orig Artic Ser; 1984; 20(1):233-41. PubMed ID: 6329364 [No Abstract] [Full Text] [Related]
37. [1st experiments concerning the vaccination of horses against rhino-pneumonia (viral abortion of mares) with a live vaccine from cell cultures]. Mayr A; Pette J Bull Off Int Epizoot; 1968 May; 70(1):133-40. PubMed ID: 4330974 [No Abstract] [Full Text] [Related]
38. Varicella vaccine. Med Lett Drugs Ther; 1995 Jun; 37(951):55-7. PubMed ID: 7783692 [No Abstract] [Full Text] [Related]
39. The herpesvirus group. Melnick JL Bull Pan Am Health Organ; 1977; 11(2):153-6. PubMed ID: 198052 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of the efficacy of a modified-live combination vaccine against abortion caused by virulent bovine herpesvirus type 1 in a one-year duration-of-immunity study. Ficken MD; Ellsworth MA; Tucker CM Vet Ther; 2006; 7(3):275-82. PubMed ID: 17039450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]